outlookNIFTY:

Nifty  started new series with positive bias , gaining around 1.5 % at the closing .Prices initially opened with gap up and started moving down but after few hours of trading nifty again rebound and closed at 14761. Metals and cement  were the major gainers while  majority sector was with positive bias.

The market saw increased volatility with sharp bouts of selling & buying . High volatility means high risk high rewards as well as well . We prefer to not participate in a high volatile environment where there is no clear sense of direction. We are advising ours readers to avoid trading the index , wait for volatility to cool off and a consolidation or trading range to be visible.

Nifty has to continuous to hold above 14700 zone to extend its moves towards 14900 or 15000, while on the downside major support will comes at 14600-14500.

BANK NIFTY:

Bank nifty opened at 35374  with a gain almost 500 and as the day progressed index did not move so much and closed almost near to open price with a gain of 1.41%. It was a choppy day in the index where prices have moved in both the direction , after a big candle it was normal for prices to move narrow and sideways in the next trading day.

We have seen some wild swing and big range days recently so its possible that prices may consolidate for time being . We should avoid trading the index and wait for a clear sense of direction.

Trade AnyTime AnyWhere With Elite Empower Mobile App

Elite-Empower-App-Promotional-Banner-img1

TECHNICAL PICKS

COMPANY  CMP B/S RATIONALE
DIVISLAB 3491 BUY The stock has given a breaKout from a narrow trading range. The stock can be buy  at CMP with a stop at  23460and for the target 3560
L&T FIN 108 BUY The stock has given a breakout  from a narrow trading range. The stock can be bought  at CMP with a stop at 104 and for the target 115.

Get All Your Mutual Fund Portfolio Returns on Your Mobile by Elite Kuber App


Elite-Kuber-Mutual-Fund-Promotional-Banner-img

DERIVATIVE PICKS

STOCK OPTION Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
L&t fin 105 ce BUY 8 CMP 4.5 14 OI increase
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
L&TFH 108 3.5 9.2 BANKBARODA 83.35 -2.9 18.9
MOTHERSUMI 231.55 7.4 7.9 BHARTIARTL 532.3 -4 13.1
RAMCOCEM 995 2.9 -0.1 MANAPPURAM 174.45 -0.8 -0.6
AARTIIND 1269 3.7 18 MGL 1158 -0.1 2.2
ASHOKLEY 129.65 1 6.5 PNB 40.8 0 10.8
                                                                        Short Covering Long Unwinding
Stocks Price Price% OI% OI Stocks Price Price % OI % OI

Top Delivery Percentage

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
JPASSOCIAT 7.15 6.72 57929994 9497619 30.62 NiftyPhrma 9375.1 1.7 81855
DRREDDY 2601.8 6.49 4485824 141906 26.22 NftyPSUBk 2964.2 1.39 81855
IDEA 44.55 5.19 48774289 2688123 7.82 IndiaVIX 19.55 1.16 81855
EXIDEIND 250.75 4.96 4124701 2771172 65.44 NiftyBank 26262.05 0.57 81855
DLF 182.8 4.52 7925047 1562487 22.37 NFPvt Bank 14845.6 0.53 81855
DALMIABHA 2358.7 4.43 191051 31184 44.68 NiftyFMCG 29390.85 -0.06 81855
DHFL 234.85 4.24 24463945 2115391 9.56 NiftyAuto 9119.3 -0.16 81852
IRB 142.65 4.16 2310849 432521 31.48 Nifty 50 10600.05 -0.53 81855
L&TFH 136.5 3.72 6121753 1126130 25.42 NiftyMetal 3272.7 -0.8 81852
FEDERALBNK 82.95 3.69 11107265 3181618 32.05 NiftyIT 13879.15 -2.84 81855

Upcoming Economic Data

   Domestic                                                                                                                                                  International
INR:  Nikkei Markit Manufacturing PMI (Feb) on 1st March, 2021

INR:  Trade Balance (Feb) on 1st  March, 2021

•USD :   ISM Manufacturing PMI (Feb) on 1st March, 2021

•USD :  OPEC Meeting  on 3rd March, 2021

Get Stock Market Recommendation By Our Research Analysts

Market-Research-Promotional-Banner-img5

News Updates

•Consumption of packaged consumer goods is set to double in India with the bottom-of-pyramid segment shrinking, younger people coming into the workforce, the divide between rural and urban consumers diminishing and a meteoric rise of the digital workforce. 140 million households are expected to be added to the aspiring and affluent set of consumers by 2030, which is “clear indication” of the growth potential of packaged consumer-facing brands.

•Natco Pharma on Friday said it has launched epilepsy treatment drug ‘Brivaracetam’ in the country. The company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing. Brivaracetam, indicated towards the treatment of epilepsy, is developed by UCB Pharma and currently marketed in India by Dr Reddy’s under the brand name Briviact.

•Home sales in the Mumbai region surged in January as the stamp duty cut and low rates continue to drive demand in India’s most expensive housing market. Sales jumped 33% over a year earlier, according to a tracker by developers’ lobby Credai-MCHI. Average value of property sold also rose 14% to Rs 66 lakh.

•State Bank of India is preparing for its mutual fund joint venture for an initial public offering, news agency Bloomberg reported on Friday. The country’s largest lender plans to ask investment banks for proposals after discussions with its board and shareholder Amundi Asset Management, it said.

Source: Economic Times,  Moneycontrol,Business Today, Livemint, Business Standard, Bloomberg Quint

Open Your Demat Account to Invest in Upcoming IPO’sDemat-and-Trading-Account-Promotion-Banner

Board Meetings

Company Name Purpose Ex-Date Company Name Purpose Ex-Date
ABHIINFRA General 02-Mar-21 THANGAMAYL Interim Dividend 02-Mar-21
COMCL General 02-Mar-21 ANANTRAJ Preferential Issue of shares 03-Mar-21
GTNINDS General 02-Mar-21 AVL Employees Stock Option Plan;General 03-Mar-21
JAGRAN Buy Back of Shares 02-Mar-21 BCPL General 03-Mar-21
JUMPNET General;Quarterly Results 02-Mar-21 DLF General 03-Mar-21
KIRLFER Interim Dividend 02-Mar-21 KREONFIN Preferential Issue of shares 03-Mar-21
MACINTR General 02-Mar-21 MAGANTR General 03-Mar-21
RANJEET General 02-Mar-21 MARICO Interim Dividend 03-Mar-21
TECHIN General;Preferential Issue of shares 02-Mar-21 OSWALEA Right Issue;Increase in Auth. Capital 03-Mar-21
TEXINFRA General;Voluntary Delisting of Shares 02-Mar-21 UNICK General 03-Mar-21

Corporate Action

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
BUTTERFLY 02-Mar-21 Interim Dividend – Rs. – 1.5000 SACHEMT 08-Mar-21 Bonus issue 1:10
KMSUGAR 02-Mar-21 E.G.M. TELESYS 08-Mar-21 E.G.M.
QUINT 02-Mar-21 Bonus issue 1:1 KEI 09-Mar-21 Interim Dividend – Rs. – 2.0000
DIGJAMLTD 03-Mar-21 Reduction of Capital THANGAMAYL 09-Mar-21 Interim Dividend
BHARATRAS 04-Mar-21 Buy Back of Shares DICIND 10-Mar-21 Final Dividend – Rs. – 6.0000
SOTL 04-Mar-21 Buy Back of Shares MARICO 10-Mar-21 Interim Dividend
HAL 05-Mar-21 Interim Dividend – Rs. – 15.0000 WANBURY 10-Mar-21 E.G.M.
RPIL 05-Mar-21 E.G.M. COALINDIA 15-Mar-21 Interim Dividend
POWERGRID 08-Mar-21 Interim Dividend SOUTHBANK 15-Mar-21 E.G.M.

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.